#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastatic gastric cancer Uterine leiomyosarcoma Microscopic polyangiitis Thymic carcinoma Amyotrophic lateral sclerosis Rectal cancer Gastrointestinal stromal tumour Ewing's sarcoma metastatic Idiopathic pulmonary fibrosis Biliary neoplasm IgA nephropathy Epilepsy with myoclonic-atonic seizures Ureteric cancer Hereditary motor and sensory neuropathy Cold type haemolytic anaemia More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Diagnostics Arterial tortuosity syndrome – Trials in Disease Pleural mesothelioma malignant – Diagnostics Splenic marginal zone lymphoma – Basic Information Pemphigus – Trials in Disease Mantle cell lymphoma stage IV – Diagnostics Mucopolysaccharidosis III – Treatment Castleman’s disease Lymphatic malformation – Basic Information Synovial sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lovotibeglogene Autotemcel Rineterkib Losmapimod EGANELISIB Msv/As Mavorixafor Zopiclone Dacarbazine Citrate D5-Ethyl-Beta-D-Glucuronide Leuprorelin Mb-Cart20.1 Topiramate Tremelimumab Leriglitazone Lenacapavir Sodium Benzylpenicillin Sodium Vb10.16 DAPIGLUTIDE Mometasone Furoate Venglustat More therapies…

    Learn about Your Condition

    Procedural headache Antithrombin III deficiency Alport's syndrome Obsessive-compulsive disorder Inner ear disorder Hepatic fibrosis Herpes simplex Cleft lip and palate Pharyngeal cancer stage I Laparoscopic surgery Polymyalgia rheumatica Angiopathy Intermittent claudication Oesophageal adenocarcinoma Petit mal epilepsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Efficacy of intravenous prasinezumab versus placebo in Parkinson’s disease patients with severe GBA mutation: a 104‑week randomized double‑blind study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    • Sodium Chloride
    France Germany Italy Luxembourg Spain Sweden

  • Efficacy of efgartigimod alfa as first‑line add‑on to IV methylprednisolone for moderate‑to‑severe attacks in patients with demyelinating diseases

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Germany

  • Oral corticosteroid tapering with ravulizumab, prednisone and prednisolone in adult patients with generalized myasthenia gravis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Prednisone
    • Ravulizumab
    • Prednisolone
    Germany Italy

  • Safety and Tolerability of Oral SUN-627 in Adults with Non‑Active Progressive Multiple Sclerosis (SPMS/PPMS) – Phase 2a Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Finland

  • Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Alks 2680
    Belgium France Germany Italy The Netherlands Spain

  • Safety and Efficacy of AST-004 in Patients with Mild Complicated Traumatic Brain Injury

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Craniocerebral injury
    The Netherlands
Previous Page
1 … 60 61 62 63 64 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!